T1	Intervention 144 220	patients with heart failure and a reduced left ventricular ejection fraction
T2	Intervention 408 572	3445 patients with symptomatic heart failure and a left ventricular ejection fraction of 45% or more to receive either spironolactone (15 to 45 mg daily) or placebo
